Anti-oxidative and inhibitory activities on nitric oxide (NO) and prostaglandin E2 (COX-2) production of flavonoids from seeds of Prunus tomentosa Thunberg

Arch Pharm Res. 2008 Apr;31(4):424-8. doi: 10.1007/s12272-001-1174-9. Epub 2008 May 1.

Abstract

Chemical investigation of the 80% Me(2)CO extract from the seeds of Prunus tomentosa led to the isolation and identification of six flavonoids: kaempferol (1), kaempferol 3-O-alpha-L-rhamnopyranoside (2; afzelin), kaempferol 3-O-beta-D-(6-acetyl)-glucopyranosyl(1-->4)-alpha-L-rhamnopyranoside (3; multiflorin A), kaempferol 3-O-beta-D-glucopyranosyl(1-->4)-alpha-L-rhamnopyranoside (4; multiflorin B), quercetin 3-O-alpha-L-rhamnopyranoside (5; quercitrin), and quercetin 3-O-beta-D-glucopyranosyl (1-->4)-alpha-L-rhamnopyranoside (6; multinoside A). Anti-oxidative and inhibitory activities on nitric oxide (NO) and prostaglandin E(2) production in interferon-gamma (INF-gamma) and lipopolysaccharide (LPS)-activated RAW 264.7 cells in vitro (COX-2) of the isolated compounds were evaluated. Compounds 1, 5, and 6 exhibited potent anti-oxidative activity in the DPPH radical scavenging assay with IC(50) values of 57.2, 59.4, and 54.3 microg/mL respectively. The positive control, ascorbic acid, had an IC(50) of 55.5 mug/mL. Compounds 1, 5, and 6 also reduced COX-2 levels in a dose dependent manner with IC(50) values of 10.2, 8.7, and 9.6 microg/mL respectively, with the positive control, indomethacin, having an IC(50) of 5.1 microg/mL. All six compounds inhibited NO production in a dose dependent manner with IC(50) values of 35.1, 42.8, 40.0, 44.8, 43.7, and 43.9 microg/mL respectively, while the positive control, L-NMMA, had an IC(50) of 42.1 microg/mL.

MeSH terms

  • Animals
  • Cell Survival / drug effects
  • Chromones / pharmacology
  • Cyclooxygenase 2 / metabolism*
  • Cyclooxygenase 2 Inhibitors / isolation & purification
  • Cyclooxygenase 2 Inhibitors / pharmacology*
  • Dinoprostone / metabolism*
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / isolation & purification
  • Enzyme Inhibitors / pharmacology*
  • Flavonoids / isolation & purification
  • Flavonoids / pharmacology*
  • Free Radical Scavengers / isolation & purification
  • Free Radical Scavengers / pharmacology*
  • Glycosides / pharmacology
  • Indomethacin / pharmacology
  • Interferon-gamma / metabolism
  • Kaempferols / pharmacology
  • Lipopolysaccharides / pharmacology
  • Macrophages / drug effects
  • Macrophages / enzymology
  • Mannosides / pharmacology
  • Mice
  • Molecular Structure
  • Nitric Oxide / metabolism*
  • Nitric Oxide Synthase / antagonists & inhibitors*
  • Nitric Oxide Synthase / metabolism
  • Proanthocyanidins / pharmacology
  • Prunus* / chemistry
  • Quercetin / analogs & derivatives
  • Quercetin / pharmacology
  • Seeds
  • omega-N-Methylarginine / pharmacology

Substances

  • Chromones
  • Cyclooxygenase 2 Inhibitors
  • Enzyme Inhibitors
  • Flavonoids
  • Free Radical Scavengers
  • Glycosides
  • Kaempferols
  • Lipopolysaccharides
  • Mannosides
  • Proanthocyanidins
  • kaempferol-3-O-glucopyranosyl-1-4-rhamnopyranoside
  • omega-N-Methylarginine
  • quercitrin
  • Nitric Oxide
  • afzelin
  • multiflorin A
  • kaempferol
  • Interferon-gamma
  • Quercetin
  • Nitric Oxide Synthase
  • Ptgs2 protein, mouse
  • Cyclooxygenase 2
  • Dinoprostone
  • Indomethacin